Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martha Nason

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Clinical Researcher (Alexandria, Va.)|February 19, 2019
A Survey on Including Risks in the New "Key Information" Section of an Informed Consent FormKatelyn Le, Stacy Kopka, Doreen Chaitt, et al.
The Lancet. HIV|May 13, 2019
Taking stock of the present and looking ahead: envisioning challenges in the design of future HIV prevention efficacy trialsHolly Janes, Deborah Donnell, Peter B Gilbert, et al.
The Journal of Infectious Diseases|November 2, 2013
No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based studyNicolas Wentzensen, Martha Nason, Mark Schiffman, et al.
Critical Care Medicine|March 18, 2022
Preintubation Sequential Organ Failure Assessment Score for Predicting COVID-19 Mortality: External Validation Using Electronic Health Record From 86 U.S. Healthcare Systems to Appraise Current Ventilator Triage AlgorithmsMichael B Keller, Jing Wang, Martha Nason, et al.
Clinical Trials (London, England)|May 27, 2021
COVID-19 vaccine trials: The potential for "hybrid" analysesThomas R Fleming, Martha Nason, Philip R Krause, et al.
Open Forum Infectious Diseases|February 5, 2020
Cardiovascular Biomarker Profile on Antiretroviral Therapy Is Not Influenced by History of an IRIS Event in People With HIV and Suppressed ViremiaAurelie Gouel-Cheron, Martha Nason, Adam Rupert, et al.
Clinical Trials (London, England)|February 4, 2021
COVID-19 vaccine trials: The use of active controls and non-inferiority studiesThomas R Fleming, Philip R Krause, Martha Nason, et al.
The Journal of Infectious Diseases|October 26, 2020
Clinical and Immunologic Predictors of Mycobacterium avium Complex Immune Reconstitution Inflammatory Syndrome in a Contemporary Cohort of Patients With Human Immunodeficiency VirusKimberly F Breglio, Caian L Vinhaes, María B Arriaga, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 30, 2006
Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene insertsRebecca L Sheets, Judith Stein, T Scott Manetz, et al.
AIDS (London, England)|May 9, 2021
Broadly neutralizing antibody-mediated protection of macaques against repeated intravenous exposures to simian-human immunodeficiency virusDavid A Garber, Patricia Guenthner, James Mitchell, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Clinical Researcher (Alexandria, Va.)|February 19, 2019
A Survey on Including Risks in the New "Key Information" Section of an Informed Consent FormKatelyn Le, Stacy Kopka, Doreen Chaitt, et al.
The Lancet. HIV|May 13, 2019
Taking stock of the present and looking ahead: envisioning challenges in the design of future HIV prevention efficacy trialsHolly Janes, Deborah Donnell, Peter B Gilbert, et al.
The Journal of Infectious Diseases|November 2, 2013
No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based studyNicolas Wentzensen, Martha Nason, Mark Schiffman, et al.
Critical Care Medicine|March 18, 2022
Preintubation Sequential Organ Failure Assessment Score for Predicting COVID-19 Mortality: External Validation Using Electronic Health Record From 86 U.S. Healthcare Systems to Appraise Current Ventilator Triage AlgorithmsMichael B Keller, Jing Wang, Martha Nason, et al.
Clinical Trials (London, England)|May 27, 2021
COVID-19 vaccine trials: The potential for "hybrid" analysesThomas R Fleming, Martha Nason, Philip R Krause, et al.
Open Forum Infectious Diseases|February 5, 2020
Cardiovascular Biomarker Profile on Antiretroviral Therapy Is Not Influenced by History of an IRIS Event in People With HIV and Suppressed ViremiaAurelie Gouel-Cheron, Martha Nason, Adam Rupert, et al.
Clinical Trials (London, England)|February 4, 2021
COVID-19 vaccine trials: The use of active controls and non-inferiority studiesThomas R Fleming, Philip R Krause, Martha Nason, et al.
The Journal of Infectious Diseases|October 26, 2020
Clinical and Immunologic Predictors of Mycobacterium avium Complex Immune Reconstitution Inflammatory Syndrome in a Contemporary Cohort of Patients With Human Immunodeficiency VirusKimberly F Breglio, Caian L Vinhaes, María B Arriaga, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 30, 2006
Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene insertsRebecca L Sheets, Judith Stein, T Scott Manetz, et al.
AIDS (London, England)|May 9, 2021
Broadly neutralizing antibody-mediated protection of macaques against repeated intravenous exposures to simian-human immunodeficiency virusDavid A Garber, Patricia Guenthner, James Mitchell, et al.
Pageof 8